Medicare now covers HIV prevention at your pharmacy, not just doctor's office
H.R. 7189 — PrEP Access Act · Filed by Mark Pocan (D-WI) · 21 cosponsors · Introduced Jan 21, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare Part B coverage to include HIV prevention services (like PrEP and PEP medications, screening, and counseling) when provided by pharmacists, not just physicians. Medicare will pay 80% of the cost (capped at 85% of the physician payment rate), and pharmacists cannot balance-bill patients for these services. The change takes effect January 1, 2027.
Why we flagged it
The bill's core mechanism is straightforward: it adds a new covered service category (pharmacist-provided HIV prevention) to Medicare Part B and sets payment rates. This is routine healthcare coverage policy, not a hidden rider or carve-out.
What the text implies
- Pharmacist scope-of-practice expansion may vary by state law; beneficiaries in states with restrictive pharmacy regulations may see limited practical access despite federal coverage.
- Payment at 85% of physician rates may incentivize pharmacists to provide these services, but actual uptake depends on state licensing, pharmacy chain policies, and pharmacist training availability.
The full analysis lists 4 implications of this text.
Who stands to gain
Pharmaceutical manufacturers (PrEP/PEP drug volume increase); Pharmacy chains and independent pharmacies (new billable service line); Clinical laboratory companies (increased HIV screening test volume)